Cannara Biotech Inc. has finalized a non-binding Letter of Intent (LOI) with the Société québécoise du cannabis (the “SQDC”). With this LOI, Cannara will dedicate its entire first year production of premium quality cannabis to its home market of Québec. The Company also announced the hiring of its 100th employee at its facility in Farnham, Québec with more hiring forthcoming.
“Our approach has always been Made in Québec, For Québec,” said Zohar Krivorot, CEO of Cannara. “With our library of top genetics and purpose-built indoor facility, our now 100-person Farnham team continues to excel as we ramp up our activities. It is our focus to become the leading, go-to cannabis producer for consumers in Quebec.”
The LOI with the SQDC is expected to convert to a comprehensive purchase order once Cannara is granted its Sales License Amendment from Health Canada. Certificates of Analysis (CoA) from its first two harvests have already been submitted for approval. The quantities outlined in the LOI would result in all of Cannara’s initial 15,000 kg capacity being allocated to its home province of Québec with supply beginning in the second half of this year.
Cannara’s state-of-the art facility is strategically located just 45 minutes outside of Montreal in the city of Farnham where the company has direct access to the vibrant local economy and workforce.
Cannara Biotech Inc. has built one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in Quebec. Leveraging Quebec’s low electricity costs, Cannara Biotech Inc.’s facility will produce premium-grade indoor cannabis and cannabis-derivative products for the Quebec and Canadian markets. For more information visit www.cannara.ca